title: Serum levels of angiogenic cytokines decrease after radiotherapy in non-Hodgkin lymphomas.
abstract: OBJECTIVE
  Serum levels of angiogenic cytokines decrease after radiotherapy in patients with cancer, and this may be relevant for treatment response and progression-free survival. Herein, we set out to determine whether circulating fibroblast growth factor-2 (FGF-2), vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF) and platelet-derived growth factor-beta (PDGF-beta) decrease after radiotherapy in patients with non-Hodgkin lymphomas (NHLs) and if so, whether their decrease correlates with age, tumour histotype and stage, and radiation dose.
  
  
  METHODS
  The serum levels of FGF-2, VEGF, HGF and PDGF-beta were evaluated before and after radiotherapy by an enzyme-linked immunosorbent assay (ELISA). These levels were correlated both reciprocally and with age, histotype, stage and radiation dose.
  
  
  RESULTS
  After radiotherapy, FGF-2, VEGF and PDGF-beta, but not HGF, significantly decreased in relation to the radiation dose and response. No correlation was established between cytokine levels, except for VEGF and PDGF-beta, which decreased in parallel. Haemoglobin levels did not decrease after radiotherapy, while FGF-2, VEGF, HGF and PDGF-beta levels did not correlate with age, NHL stage and histotype.
  
  
  CONCLUSIONS
  Soluble FGF-2, VEGF and PDGF-beta levels decline after radiotherapy in NHLs, and may have predictive significance for response to treatment and recurrence.
authors.affiliation: Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine, University of Bari Medical School, Policlinico, Piazza Giulio Cesare 11, Bari, Italy. ria@dimo.uniba.it
authors.forename: Roberto
authors.initials: R
authors.lastname: Ria
authors.forename: Teresa
authors.initials: T
authors.lastname: Cirulli
authors.forename: Teresa
authors.initials: T
authors.lastname: Giannini
authors.forename: Santa
authors.initials: S
authors.lastname: Bambace
authors.forename: Gabriella
authors.initials: G
authors.lastname: Serio
authors.forename: Maurizio
authors.initials: M
authors.lastname: Portaluri
authors.forename: Domenico
authors.initials: D
authors.lastname: Ribatti
authors.forename: Angelo
authors.initials: A
authors.lastname: Vacca
authors.forename: Franco
authors.initials: F
authors.lastname: Dammacco
mesh_terms: D000328:Adult; D000368:Aged; D016207:Cytokines / Q000097:blood*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000097:blood / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D009389:Neovascularization, Pathologic
chemical_list: D016207:Cytokines
references.citation: Nat Med. 2000 Apr;6(4):389-95
references.pmid: 10742145
references.citation: Nat Med. 1999 Dec;5(12):1359-64
references.pmid: 10581076
references.citation: Eur Cytokine Netw. 2003 Jan-Mar;14(1):40-51
references.pmid: 12799213
references.citation: J Clin Oncol. 2007 Sep 10;25(26):4033-42
references.pmid: 17827451
references.citation: Cancer Res. 2007 Oct 1;67(19):8980-4
references.pmid: 17908997
references.citation: Semin Oncol. 2001 Dec;28(6):536-42
references.pmid: 11740806
references.citation: Hormones (Athens). 2006 Apr-Jun;5(2):137-46
references.pmid: 16807226
references.citation: Head Neck. 2000 Oct;22(7):666-73
references.pmid: 11002321
references.citation: Int J Oncol. 2008 Jan;32(1):41-8
references.pmid: 18097541
references.citation: Radiother Oncol. 2003 Jan;66(1):1-9
references.pmid: 12559515
references.citation: J Clin Oncol. 2001 Feb 15;19(4):1207-25
references.pmid: 11181687
references.citation: Int J Cancer. 2001 Dec 1;94(5):690-8
references.pmid: 11745464
references.citation: Int J Cancer. 2002 Sep 1;101(1):86-94
references.pmid: 12209593
references.citation: Cancer Lett. 2002 May 28;179(2):197-203
references.pmid: 11888674
references.citation: Breast Cancer Res. 2003;5(2):83-8
references.pmid: 12631386
references.citation: Br J Haematol. 2001 Dec;115(3):514-21
references.pmid: 11736931
references.citation: Cancer Metastasis Rev. 2007 Dec;26(3-4):453-67
references.pmid: 17828470
references.citation: Oncogene. 2007 Nov 29;26(54):7508-16
references.pmid: 17563752
references.citation: Nat Med. 2001 May;7(5):575-83
references.pmid: 11329059
references.citation: Am J Physiol Cell Physiol. 2002 May;282(5):C947-70
references.pmid: 11940508
references.citation: Blood. 2002 Nov 1;100(9):3344-51
references.pmid: 12384436
references.citation: Cancer Lett. 2004 Dec 8;216(1):103-7
references.pmid: 15500953